Literature DB >> 12752199

Dual-setting calcium phosphate cement modified with ammonium polyacrylate.

Luís Alberto dos Santos1, Raúl García Carrodeguas, Anselmo Ortega Boschi, Antônio Celso de Arruda.   

Abstract

alpha-Tricalcium phosphate bone cement, as formerly designed and developed by Driessens et al., consists of a powder composed by alpha-tricalcium phosphate (alpha-TCP) and hydroxyapatite (HA) seeds, and an aqueous solution of Na2HPO4 as mixing liquid. After mixing powder and liquid, alpha-TCP dissolves into the liquid and calcium deficient hydroxyapatite (CDHA), more insoluble than the former, precipitates as an entanglement of crystals, which causes the setting and hardening of the cement. alpha-TCP bone cement offers several advantages in comparison to calcium phosphate bioceramics and acrylic bone cements as bone graft and repairing material, like perfect adaptability to the defect size and shape, osteotransductibility, and absence of thermal effect during setting. The main handicap is its low mechanical strength. Therefore, approaching its mechanical strength to that of human bone could considerably extend its applications. In the present work, an in situ polymerization system based on acrylamide (AA) and ammonium polyacrylate (PA) as liquid reducer was added to alpha-TCP cement to increase its mechanical strength. The results showed that the addition of 20 wt% of acrylamide and 1 wt% AP to the liquid increased the compressive and tensile strength of alpha-TCP bone cement by 149 and 69% (55 and 21 MPa), respectively. The improvement in mechanical strength seems to be caused by a decrease of porosity and the reinforcing effect of a polyacrylamide network coexisting with the entanglement of CDHA crystals. The studied additives do not affect the nature of the final product of the setting reaction, CDHA, but promote the reduction of its crystal size.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752199     DOI: 10.1046/j.1525-1594.2003.07248.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  7 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 2.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

3.  Apatite bone cement reinforced with calcium silicate fibers.

Authors:  Mariana Motisuke; Verônica R Santos; Naiana C Bazanini; Celso A Bertran
Journal:  J Mater Sci Mater Med       Date:  2014-07-23       Impact factor: 3.896

4.  Dual setting α-tricalcium phosphate cements.

Authors:  T Christel; M Kuhlmann; E Vorndran; J Groll; U Gbureck
Journal:  J Mater Sci Mater Med       Date:  2012-12-13       Impact factor: 3.896

5.  Osteoclastic cell behaviors affected by the α-tricalcium phosphate based bone cements.

Authors:  Sun-Ae Oh; Gil-Su Lee; Jeong-Hui Park; Hae-Won Kim
Journal:  J Mater Sci Mater Med       Date:  2010-09-21       Impact factor: 3.896

6.  Reaction kinetics of dual setting α-tricalcium phosphate cements.

Authors:  Katrin Hurle; Theresa Christel; Uwe Gbureck; Claus Moseke; Juergen Neubauer; Friedlinde Goetz-Neunhoeffer
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

7.  Polymeric additives to enhance the functional properties of calcium phosphate cements.

Authors:  Roman A Perez; Hae-Won Kim; Maria-Pau Ginebra
Journal:  J Tissue Eng       Date:  2012-03-20       Impact factor: 7.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.